Imbruvica 140mg Capsules, 90 Count Treatment Pack

Imbruvica 140mg Capsule 90's

Uses:

• Mantle cell lymphoma;
• Chronic lymphocytic leukemia (blood cancer);
• Small lymphocytic lymphoma;
• Waldenstrom’s macroglobulinemia;
• Chronic graft versus host disease after the failure of systemic therapy.

Mechanism of action:

• The active ingredient, Ibrutinib, blocks a specific protein called Bruton's tyrosine kinase (BTK).
• BTK plays a key role in the survival and growth of cancer cells.
• By inhibiting BTK, Imbruvica 140mg prevents cancer cells from receiving the signals they need to grow and divide, leading to their eventual death.

Interaction with other drugs:

• Inform your healthcare professional about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products.
• Certain medications interacting with Imbruvica 140mg may reduce effectiveness by causing undesirable side effects.

Safety advice:

• Pregnancy: this medicine can harm the unborn baby. Do not take Ibrutinib Capsule unless your physician instructs you to take it.
• Breastfeeding: do not breastfeed while you are under Imbruvica 140mg capsule and for at least one week after the last dose.
• Lungs: Imbruvica 140mg capsule may cause interstitial lung disease. If you have any respiratory disorder, inform your doctor before starting the treatment.
• Liver: inform your physician before starting this treatment if you have liver problems, including hepatitis B infection.
• Alcohol: it is unknown whether it is safe to consume alcohol with the Imbruvica 140mg capsule. Please consult your doctor.
• Driving: Imbruvica 140mg capsule may cause dizziness or tiredness. Avoid driving or operating machines if you feel dizzy or tired.

Side effects:

• Serious: bleeding problems, infections, decrease in blood cell counts, heart problems, high BP, secondary cancer, tumor lysis syndrome, severe allergic reactions.
• Common: nausea, vomiting, diarrhea, tiredness, muscle and bone pain, rash and bruising, mouth sores, pneumonia, fever, chills, breathlessness, constipation, dizziness, body pain, swollen ankles and feet, increased creatinine levels in blood, heavier periods and blood in urine, blurred vision, weakness and numbness.

FAQs:

1. Can I take Imbruvica 140mg to prevent getting cancer in the future? Imbruvica 140mg is not approved for use as a cancer prevention medication, and its long-term effects on healthy individuals are not fully understood. If you are concerned about your risk of developing cancer, you should speak with your doctor about appropriate cancer screening and prevention strategies.

2. Can Imbruvica 140mg be taken with other medications? Imbruvica 140mg can interact with other medications, so it is important to inform your doctor of all medications you are taking, including prescription, over-the-counter, and herbal supplements.

3. How long do I need to take Imbruvica 140mg? The length of treatment with Imbruvica 140mg will depend on your specific condition and response to the medication. Your doctor will monitor your progress and determine the duration of treatment.

4. Can I drink alcohol while taking Imbruvica 140mg? Alcohol consumption should be avoided while taking Imbruvica 140mg, as it may increase the risk of certain side effects, such as liver damage. You should talk to your doctor about any concerns you have regarding alcohol use.

5. Can Imbruvica 140mg cure all types of cancer? Imbruvica 140mg has been shown to be effective in treating certain types of blood cancers, but its efficacy in other types of cancer is still being studied. It is important to remember that cancer is a complex disease with many different causes and factors, and there is no single cure that works for all types of cancer.

6. Should I use contraception while under this Imbruvica 140mg capsule? Yes, it is necessary to use contraception during and even after the last dose of Ibrutinb capsule. Inform your doctor if you are pregnant or think you might be or if you are planning to get pregnant.

Fact box:

• Molecule name: Ibrutinib.
• Therapeutic class: Anti Neoplastics.
• Pharmacological class: Bruton's tyrosine kinase (BTK) inhibitors.

Tags: imbruvica, cancer_treatment, drugs, pharmaceuticals, 140mg, capsules, 90_count